title: Technologies and experimental approaches at the National Institutes of Health Botanical Research Centers.
abstract: Many similarities exist between research on combinatorial chemistry and natural products and research on dietary supplements and botanicals at the National Institutes of Health (NIH) Botanical Research Centers. The technologies used at the centers are similar to those used by other NIH-sponsored investigators. All centers rigorously examine the authenticity of botanical dietary supplements and determine the composition and concentrations of the phytochemicals therein, most often by liquid chromatography-mass spectrometry. Several of the centers specialize in fractionation and high-throughput evaluation to identify the individual bioactive agent or a combination of agents. Some centers are using DNA microarray analyses to determine the effects of botanicals on gene transcription with the goal of uncovering the important biochemical pathways they regulate. Other centers focus on bioavailability and uptake, distribution, metabolism, and excretion of the phytochemicals as for all xenobiotics. Because phytochemicals are often complex molecules, synthesis of isotopically labeled forms is carried out by plant cells in culture, followed by careful fractionation. These labeled phytochemicals allow the use of accelerator mass spectrometry to trace the tissue distribution of (14)C-labeled proanthocyanidins in animal models of disease. State-of-the-art proteomics and mass spectrometry are also used to identify proteins in selected tissues whose expression and posttranslational modification are influenced by botanicals and dietary supplements. In summary, the skills needed to carry out botanical centers' research are extensive and may exceed those practiced by most NIH investigators.
authors.affiliation: Botanical Center for Age-Related Disease, Purdue University-University of Alabama at Birmingham, West Lafayette, IN, USA. sbarnes@uab.edu
authors.forename: Stephen
authors.initials: S
authors.lastname: Barnes
authors.forename: Diane F
authors.initials: DF
authors.lastname: Birt
authors.forename: Barrie R
authors.initials: BR
authors.lastname: Cassileth
authors.forename: William T
authors.initials: WT
authors.lastname: Cefalu
authors.forename: Floyd H
authors.initials: FH
authors.lastname: Chilton
authors.forename: Norman R
authors.initials: NR
authors.lastname: Farnsworth
authors.forename: Ilya
authors.initials: I
authors.lastname: Raskin
authors.forename: Richard B
authors.initials: RB
authors.lastname: van Breemen
authors.forename: Connie M
authors.initials: CM
authors.lastname: Weaver
mesh_terms: D000818:Animals; D001682:Biological Availability; D001709:Biotechnology / Q000379:methods*; D005591:Chemical Fractionation; D015180:Electrophoresis, Gel, Two-Dimensional; D006801:Humans; D009316:National Institutes of Health (U.S.); D020411:Oligonucleotide Array Sequence Analysis; D010449:Peptide Mapping; D008517:Phytotherapy; D010944:Plants; D053719:Tandem Mass Spectrometry; D014018:Tissue Distribution; D014481:United States; D015262:Xenobiotics
chemical_list: D015262:Xenobiotics